Success Stories
While there have been countless success stories from °Ç¸çºÚÁÏ startups, a handful of our companies have enjoyed particularly notable exits.
Lucid Diagnostics
in 2021. The company’s esophageal cancer prevention tests were developed jointly by medical school faculty at CWRU and University Hospitals. .
Rodeo Therapeutics
Publicly traded biopharmaceutical company in 2020, with the potential for up to $666 million if developmental milestones are reached. .
PolymerPlus
In 2020, , a Cleveland-based polymeric development company founded at CWRU, for $25 million.
NervGen Pharma
Vancouver-based NervGen Pharma Corp., a company founded to develop regenerative-medicine technology licensed from CWRU, in 2019. .
View More of Our Startup Portfolio
By the Numbers
$50 million+
Amount of follow-on investment CWRU startups have attracted
100+
Startup companies from CWRU since 2001
$600 million+
Amount raised by CWRU’s portfolio of spinoffs since 2017
Get in Touch
Looking to launch your own startup at °Ç¸çºÚÁÏ? We’re here to help.
Daniel Pendergast, MBA, MSE
Executive DirectorTechnology Transfer OfficeEmail: daniel.pendergast@case.edu
Phone: 216.368.0184